Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbive, Alessa, Amicus, Amryt, Ascletis, Bavarian Nordic, Bergenbio, Bluebird, Cantargia, Crestone, Cullinan, Iaso, Incyte, Kiniksa, Liminal, Moderna, Neoimmunetech, Novo Nordisk, Spinogenix Takeda, VBI.